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In total 14 stents were used: 6 Palmaz-Schatz, 3 AVE and 5 Wallstent. The
images of all 14 coronary segments encompassing the full stent length and
the adjacent reference segments were acquired by using a motorized pull-
back at a constant speed (1 mm/s) and immediately processed in the inter-
ventional suite using an automated contour detection algorithm based on
acoustic quantification (Figure). Residual percent area stenosis (%AS) of the
stented segment, automatically measured on-line after 3-D reconstruction.
was compared with ICUS measurements obtained by direct review of the
video-tape. In three pts studied before stent implantation on-line 3-D recon-
struction facilitated the selection of the stent length by measuring length of
dissection and distance between stenosis and left main or diagonal branch.
After stent implantation. the absence of stent overlapping in three patients
receiving multiple stents and the relationship with side branches could be
assessed. The visual information from the 3-D longitudinal views and the
on-line measurements triggered additional balloon inflations in 5 pts. The
selection of frames and the measurement from tape required a longer time
than 3-D reconstruction and measurement (4.4 vs 2.35 min. p < 0.0011 and
resulted in a slight underestimation of the residual %AS with 3 pts showing a
>20% %AS with 3-D not recognized from tape analysis, Conclusion: On-line
3-D reconstruction of ICUS for intracoronary stenting facilitates stent selec-
tion, evaluates adequate stent deployment by rapidly and accurately measur-
ing residual intrastent stenosis and detecting its relationship with anatomic
landmarks.
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CARDIAC PACING
Dual-Chamber Pacing for Patients with
Hypertrophic Obstructive Cardiomyopathy: A
Prospective Randomized, Double-Blind
Crossover Trial
Rick A. Nishimura. Jane M. Trusty, David L. Hayes. Thomas G. Allison, David
R. Holmes Jr.. Sharonne N. Hayes, Raul E. Espinosa, John D. Symanski, A.
Jamil Tajik. Mayo Clinic. Rochester, MN
Implantation of a dual-chamber permanent pacemaker (PPM) has recently
been proposed as a therapeutic alternative for patients with hypertrophic ob-
structive cardiomyopathy (HOCM). To objectively determine the short-term
benefit of PPM, we entered 11 patients with severely symptomatic HOCM
(mean age, 53 ± 13 years; 7 males, 4 females) into a prospective randomized,
double-blind crossover trial with 2 months of continuous atrial synchronous
pacing (000) and 2 months of backup pacing (WI). All medications were
continued throughout the study. Clinical symptoms. oxygen consumption
treadmills. and Doppler echocardiography were performed at baseline and
after each ofthe two arms. During the 000 arm. 62% experienced subjective
symptomatic improvement and 37% admitted to symptomatic improvement
in the WI arm. The data at baseline and after each of the two arms for maxi-
mum treadmill time (TMET-max). maximum oxygen consumption (V02-maxl,
and Doppler outflow tract gradient (GRAD) are shown:
TMET-max (min) V02-max (mUkg/min) GRADlmmHg)
BASE 5.7 ± 1.9 19.0 ± 5.8 76 ± 20
WI 60 ± 2.3 200 ± 5.8 56 ± 25
DOD 60 ± 1.7 200 ± 60 47 ± 27'
*p < 0.05 VS. baseline
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A new device (prostar'", Perclose. Inc.) was developed to close femoral
artery access sites percutaneously following coronary interventions in fully
anticoagulated patients. The catheter deploys four needles with two pairs
of sutures around the hole of femoral artery access sites. The sutures are
then tied to close the arteriotomy site mechanically to achieve immediate
hemostasis. As a pilot phase, the device was tested in six centers. The device
was used immediately following coronary intervention in 91 access sites.
Despite an average ACT at the time of the procedure of >300 seconds. im-
mediate complete hemostasis was achieved in 82 sites (90%). The devices
were not appropriately positioned in 8 cases and procedures were aborted
followed by reinsertion of a sheath or manual compression. Two patients
(2.2%) required surgical repair of the femoral artery; one with device me-
chanical failure and one with bleeding from the initial puncture site in the
posterior wall despite successful closure of the sheath site in the front wall.
There were no AV fistulae or pseudoaneurysms requiring surgery and no in-
fection, distal embolism or need for blood transfusion.
In conclusion. this pilot study suggests that this suture mediated closure
device appears to provide safe and effective hemostasis at the femoral ac-
cess site in fully anticoagulated patients following coronary interventions.
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D. Kravitz, Steven P. Kutalek. Hahnemann University, Philadelphia, PA
Dual chamber(DC) pacing has proven effective in reducing the left ventricular
outflow tract gradient (LVOTG) in most patients (pts) with HOCM refractory
to drug therapy. However, optimal pacemaker (PM) programming including
pacing mode and atrioventricular delay (AVO) has not been established. Ac-
cordingly, we performed continuous-wave transthoracic Doppler echocardio-
graphy on 7 pts with DC PMs (5 male, 2 female, mean age 64.7 ± 12.7 yearsl
with HOCM and a resting peak LVOTG exceeding 25 mmHg to evaluate the
effects on peak LVOTG of atrial synchronous pacing (VDD) and AV sequential
pacing (000) at 10 bpm above sinus rhythm while varying the AVO in steps
of 20 msec to a minimum of 40 msec.
Conclusion: PPM for patients with HOCM provides subjective improve-
ment and decrease in gradient for a select group of patients. However. not
all patients will respond to PPM, and there is no overall statistically signifi-
cant improvement in objective exercise parameters on short-term follow-up.
000 PPM should not be routinely implanted in all patients with HOCM until
further results of larger prospectively randomized trials are available.
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Conclusions: 1) At AVO of 100 to 140 msec, 000 pacing significantly re-
duced the peak LVOTG while VDD pacing did not. 2) At AVO less than 100
msec, VDD pacing significantly reduced peak LVOTG only at AVO of 40 msec,
while 000 pacing at 10 bpm above sinus rhythm reduced peak LVOTG at all
AVO used. Therefore PMs which have the capabilityto program different AVO
for VDD and 000 modes and that provide programmable AVOs less than 60
msec are optimal for HOCM pts.
Percutaneous Vascular Surgery: Suture Mediated
Percutaneous Closure of Femoral Artery Access
Site Following Coronary Intervention
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